Wells Fargo
CAMP icon

Wells Fargo’s CAMP4 Therapeutics CAMP Stock Holding History

Wells Fargo’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Buy
+28,858
New +$124K ﹤0.01% 5435
2025
Q3 		– Sell
-119
Closed -$173 – 7116
2025
Q2 		$173 Sell
119
-3,662
-97% -$7.29K ﹤0.01% 6449
2025
Q1 		$15.1K Buy
3,781
+205
+6% +$992 ﹤0.01% 5784
2024
Q4 		$18.7K Buy
+3,576
New +$29.4K ﹤0.01% 5787

Other funds holding CAMP

JT
Jupiter Topco New York $245B AUM
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wells Fargo's CAMP Position: Q2 2026 in Review

Wells Fargo opened a new position in CAMP4 Therapeutics (CAMP) in Q2 2026: 28,858 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #5435 among its holdings. This is a return to the name: Wells Fargo previously reported a position in CAMP as recently as Q2 2025.

Wells Fargo first reported a position in CAMP in Q4 2024 and has held it in 4 quarters since. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Wells Fargo held 28,858 shares of CAMP4 Therapeutics worth $126K as of Q2 2026.
  • CAMP4 Therapeutics was a new Wells Fargo position in Q2 2026.
  • CAMP4 Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5435 holding.
  • Wells Fargo first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.